Medx Health

Medx Health EBIT per Share

The EBIT per Share of Medx Health (MDX.V) as of Oct 17, 2026 is -0.02 CAD. In the previous year, EBIT per Share was -0.01 CAD — a change of 96.71% (lower).

EBIT per Share

-0.02CAD

YoY

96.71%

Last updated:

EBIT per Share of Medx Health is 2025 -0.02 CAD. EBIT per Share of Medx Health was 2024 -0.01 CAD. It decreases by 96.71% lower compared to the previous year.

The Medx Health EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2020
-0.02 CAD
Jan 1, 2021
-0.03 CAD
Jan 1, 2022
-0.02 CAD
Jan 1, 2023
-0.01 CAD
Jan 1, 2024
-0.01 CAD
Jan 1, 2025
-0.02 CAD
Jan 1, 2026 (e)
-14.26 CAD
Jan 1, 2027 (e)
0.41 CAD
The Medx Health EBIT per Share history
YEAREBIT per ShareYoY
est0.41CAD-102.90%
est-14.26CAD+82,352.30%
-0.02CAD+96.71%
-0.01CAD-5.22%
-0.01CAD-55.88%
-0.02CAD-15.89%
-0.03CAD+45.19%
-0.02CAD-21.02%
-0.02CAD-27.75%
-0.03CAD+125.85%
-0.01CAD+6.61%
-0.01CAD+381.63%
-0.00CAD+22.69%
-0.00CAD-39.80%
-0.00CAD-90.26%
-0.04CAD+83.29%
-0.02CAD-34.39%
-0.03CAD-69.69%
-0.10CAD-10.81%
-0.11CAD-20.63%
-0.14CAD+69.94%
-0.08CAD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Medx Health Stock analysis

What does Medx Health do? Medx Health Corp, trading under the ticker MDX.V, is a Canadian company headquartered in Mississauga, Ontario. The company went public on February 12, 2008, and operates within the Health Care sector, specifically in the Health Care industry. Medx Health Corp develops, manufactures, and sells medical devices and software. Its primary focus is on skin health, utilizing SIAscopy technology for skin-related screening tools. The company offers a telemedicine platform called SIAscopy on DermSecure, which integrates its SIAscopy scanning technology for web-based operations. Products include SIAMETRICS, SIMSYS, and MoleMate, which are hand-held devices that use light-based technology to examine moles and lesions up to two millimeters beneath the skin surface in a pain-free, non-invasive manner. These devices are designed for the rehabilitation market, providing phototherapy treatments using low-level laser and light-emitting diode technology to address pain and tissue damage. The company's offerings are centered around non-invasive skin screening and phototherapeutic applications, targeting both diagnostic and therapeutic needs within the health care sector. Medx Health Corp's products are intended for medical professionals and patients seeking advanced, non-invasive solutions for skin health management and rehabilitation. Medx Health is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Medx Health stock

EBIT per Share of Medx Health is -0.02 CAD in 2025.

EBIT per Share of Medx Health changed from -0.01 CAD to -0.02 CAD, representing a 96.71% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share Medx Health since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Medx Health

All Key Metrics — Medx Health